Latest In Pharmaceutical & Health Care
The sale includes the company's pharmaceutical and medical products distribution business in China.
RxCrossroads will become part of the companys McKesson Specialty Health business.
First quarter sales grew 2 percent year-over-year.
Fourth-quarter sales increase 4.2 percent year-over-year.
Sales for the third quarter decreased 3.4 percent year-over-year.
Today Drug Channels Institute analysis of the dynamic prescription drug distribution industry.
Acquisition valued at $185 million includes clinical and financial solutions.
Year-to-date sales increased 4.3 percent year-over-year.
Fourth-quarter sales up 5 percent year-over-year.
On an organic local-currency basis, sales increased 3.5 percent for the diversified manufacturer.
Sales for the first half increased 6.7 percent year-over-year.
Sales for the first six months also increased 4 percent year-over-year.
